This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Digital Week: Oligonucleotide & Peptide Therapeutics
May 2022

Andrew Kennedy, Ph.D.
Global Product Manager at Gyros Protein Technologies


Andrew Kennedy is the Global Product Manager for the Peptides Business of Gyros Protein Technologies and an experienced process development peptide chemist. After completing his PhD in Organic Chemistry at the University of Glasgow under the supervision of Professor Graeme Cooke, he then went on to specialize in Peptide Chemistry Process Development and Manufacturing with a major peptide manufacturer. He has also held several senior scientist positions in the medical devices field focusing on verification and validation of novel medical devices and release of products to market. Currently, Dr Kennedy specializes in novel peptide synthesis applications and development of automated SPPS technologies with Gyros Protein Technologies.

Agenda Sessions

  • Development, Optimization and Scale Up of Therapeutic Peptides: Approaches to Solid Phase Synthesis & Purification